Immune Pharmaceuticals, Inc. (NYSE:IMNP)
Immune Pharmaceuticals, Inc. (NYSE:IMNP) represented a move of -3.65 percent or $0.01 per share and closed its previous day trading session at $0.33. 576867 Shares were traded in the last trading session with an Average Volume of 1.53 Million Shares. The stock currently has a Market Capitalization of 5.98 Million.
Immune Pharmaceuticals Ltd. is a biopharmaceutical company which is engaged in the development of monoclonal antibodies for the treatment of inflammatory diseases and cancer. The company operates primarily in Israel and the United States. Immune Pharmaceuticals Inc., formerly known as EpiCept Corporation, is based in in Herzliya Pituach, Israel.
The stock traded between $0.320 and $5.020 over 1-Year time period showing its price to sales ratio of 0. Immune Pharmaceuticals, Inc. (NYSE:IMNP) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-40.67 and 200-Day Simple Moving Average of $-76.67. Its Price to Free Cash Flow is 0 and Price to Book of 6.55.